Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ivonescimab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06760520
What this trial is testing

Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
The First Affiliated Hospital of Zhengzhou University 40
Testing effectiveness (Phase 2)Looking for participantsNCT07070479
What this trial is testing

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

Who this might be right for
Recurrent or Metastatic Nasopharyngeal Carcinoma
Ming-Yuan Chen 208
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06993025
What this trial is testing

Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies

Who this might be right for
Biliary Tract Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07647016
What this trial is testing

Trastuzumab Deruxtecan Plus ivonescImab for Hormone Receptor-positive HER2 Negative Advanced Breast Cancer Study

Who this might be right for
Breast Cancer
Fudan University 53
Testing effectiveness (Phase 2)Looking for participantsNCT06844422
What this trial is testing

Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)

Who this might be right for
Pancreatic Cancer
Shandong Cancer Hospital and Institute 37
Large-scale testing (Phase 3)Looking for participantsNCT05899608
What this trial is testing

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

Who this might be right for
Non-Small Cell Lung Cancer
Summit Therapeutics 1,600
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07753824
What this trial is testing

A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)

Who this might be right for
Phase IIIvonescimabIntraperitoneal+3 more
M.D. Anderson Cancer Center 30
Large-scale testing (Phase 3)Looking for participantsNCT06767514
What this trial is testing

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Who this might be right for
Non-Small Cell Lung Cancer
Summit Therapeutics 780
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07095803
What this trial is testing

Ivonescimab (PD-1/VEGF Bispecific Antibody) Plus Radiofrequency Ablation for Multiple Advanced Tumors After PD-1 Therapy Failure

Who this might be right for
Multiple Advanced Tumors After PD-1 Therapy Failure
Sheng Zhang 60
Testing effectiveness (Phase 2)Looking for participantsNCT06925724
What this trial is testing

Ivonescimab in People With Endometrial and Cervical Cancers

Who this might be right for
Endometrial CancerCervical Cancer
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07244965
What this trial is testing

Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer

Who this might be right for
LOCALLY ADVANCED CERVICAL CANCERS
Women's Hospital School Of Medicine Zhejiang University 42
Not applicableLooking for participantsNCT07359040
What this trial is testing

Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerNeoadjuvant TherapyPD-1 Inhibitors+1 more
Peking University People's Hospital 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06991491
What this trial is testing

Ivonescimab With GnP and SBRT in Patients With Metastatic Pancreatic Cancer (WGOG-PAN 004)

Who this might be right for
Pancreatic Cancer
West China Hospital 29
Testing effectiveness (Phase 2)Looking for participantsNCT07245446
What this trial is testing

Ivonescimab in First-Line ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Akeso 180
Testing effectiveness (Phase 2)Looking for participantsNCT06672575
What this trial is testing

A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

Who this might be right for
Glioblastoma
M.D. Anderson Cancer Center 45
Early research (Phase 1)Not Yet RecruitingNCT07614646
What this trial is testing

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 in Combination With Ivonescimab in Sq-NSCLC Patients

Who this might be right for
Squamous Non-Small Cell Lung Cancer sqNSCLC
Everest Medicines (Beijing) Co., Ltd. 13
Testing effectiveness (Phase 2)Looking for participantsNCT07158489
What this trial is testing

Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC

Who this might be right for
NSCLCNSCLC (Advanced Non-small Cell Lung Cancer)
Swiss Cancer Institute 47
Testing effectiveness (Phase 2)Looking for participantsNCT07188103
What this trial is testing

Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital 37
Large-scale testing (Phase 3)Looking for participantsNCT07228832
What this trial is testing

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Summit Therapeutics 600
Testing effectiveness (Phase 2)UnknownNCT06375486
What this trial is testing

Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.

Who this might be right for
Hepatocellular Carcinoma Non-resectableHepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Next Page